Literature DB >> 3545582

The microbiology of premature rupture of the membranes.

J M Miller, J G Pastorek.   

Abstract

The foregoing discussions bring to mind several salient facts: Although numerous barriers to infection exist, this aspect is understood incompletely. Conclusions on the pathogenicity or nonpathogenicity of certain organisms are often made from studies with very small numbers of patients, or in very specific patient populations. When such entities as low birth weight, premature labor, and PROM, which are all obviously related to some extent, are studied, very complicated analyses on large numbers of patients are required. Most of the organisms discussed are considered to be sexually transmitted. Because STDs are generally recognized to travel together in the same patient populations, the statistics necessary to separate one organism from another are complex indeed. The previous discussion notwithstanding, it is extremely difficult to form a solid conclusion about relation of these organisms to PROM with confidence. Many more patients need to be studied through many more pregnancies. In addition, differences among population subgroups make extrapolation extremely difficult. Currently the Louisiana State University is participating in a large, multicenter, collaborative study under the auspices of the National Institutes of Health. This study should provide an adequate data base concerning most of the isolates discussed and potential adverse outcomes of pregnancy. Then definitive statements may be made regarding both the screening of pregnant women and initiation of selective therapy. Specific management recommendations are discussed by Nagey and Saller in this symposium.

Entities:  

Mesh:

Year:  1986        PMID: 3545582     DOI: 10.1097/00003081-198612000-00004

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  1 in total

1.  [Intravenous human immunoglobulin in preventing amniotic infection in premature rupture of fetal membranes].

Authors:  M Höckel; R Zielberg; A Queisser; T Beck; R Lissner; H Stopfkuchen
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.